Thor Medical produces and supplies alpha-particle-emitting radioisotopes used in targeted cancer therapies. Its process separates naturally occurring decay products from thorium to deliver materials such as radium-224 and lead-212 to radiopharmaceutical developers and partners. The company sits upstream of drug developers, focusing on isotope supply rather than finished oncology drugs.
| Year | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| 2022 | 0 | — | -311.2 | — |
| 2023 | 0 | — | -26.6 | — |
| 2024 | 0 | — | -42.2 | — |
| 2025 | 0.4 | — | -58 | — |
All markets — KeepWinning global stock screener
Other companies on Oslo: Salmon Evolution ASA (SALME), Reach Subsea ASA (REACH), NorAm Drilling AS (NORAM), Skue Sparebank (SKUE), Nordhealth AS (NORDH), Deep Value Driller AS (DVD)